Showing 1,601 - 1,620 results of 100,360 for search '(( 5 fold decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.45s Refine Results
  1. 1601
  2. 1602
  3. 1603
  4. 1604

    DataSheet1_Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain.docx by Malene Brohus (840080)

    Published 2023
    “…In contrast, the arrhythmogenic CaM-N98S variant only induced a 1.5-fold reduction in Na<sub>V</sub>1.5 binding and only at 4 µM Ca<sup>2+</sup>. …”
  5. 1605
  6. 1606

    A random forest model demonstrates the patient factors that were relatively different in 2022 compared to other years, identifying the factors that likely contributed to the increa... by Emily Lehan (19469130)

    Published 2024
    “…Features with the highest relative importance to predicting visits in 2022 were (in decreasing order): a longer stay, a visit later in the day, a diagnosis of an infectious illness, younger age, and a triage acuity of CTAS 3, “urgent” (C). …”
  7. 1607
  8. 1608
  9. 1609
  10. 1610

    Fold change in hsa-miR 1246 and F8 mRNA levels in HA patients compared to normal donors. by Tewarit Sarachana (229926)

    Published 2015
    “…<p>(<b>A</b>) The fold change in has-miR 1246 was determined by RT-PCR. …”
  11. 1611
  12. 1612
  13. 1613

    Shortening of mTL anticipates accumulation of DDR markers, decrease in cell proliferation and increase in apoptotis with age. by Madalena C. Carneiro (102302)

    Published 2016
    “…Proliferative tissues, A) gut B) kidney marrow and C) testis, show a sustained decrease in cell proliferation by 12 months of age in <i>tert</i><sup><i>-/-</i></sup> (panels g, i) and by 36 months in WT tissues (panels f, h and j). …”
  14. 1614
  15. 1615
  16. 1616
  17. 1617
  18. 1618
  19. 1619
  20. 1620

    <i>In vivo</i> treatment with entinostat decreases Foxp3 expression in Tregs and inhibits Tregs function. by Li Shen (110858)

    Published 2012
    “…Cells were harvested from spleens and lymph nodes. A, <i>In vivo</i> entinostat treatment decreased the expression level of Foxp3 in CD4<sup>+</sup>Foxp3<sup>+</sup> (Treg) cells. …”